Phase I/II Study of DFP-10917 in Patients With Acute Leukemia
Clinical trial NCT01702155 · COMPLETED
Trial details
- NCT number
- NCT01702155
- Sponsor
- Delta-Fly Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-10
- Primary completion
- 2017-01-18
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.